title: TRB3 is a PI 3-kinase dependent indicator for nutrient starvation.
abstract: We have identified TRB3, a human homologue of Drosophila tribbles, as a novel transcriptional target of phosphatidylinositol (PI) 3-kinase. TRB3 expression is remarkably reduced in prostate cancer PC-3 cells after inhibition of PI 3-kinase. TRB3 expression is furthermore controlled by nutrient supplies: Both the lack of glucose or amino acids results in a substantial increase in TRB3 protein levels in a PI 3-kinase-dependent manner. This increase is reversed by the addition of fresh nutrients. Stress stimuli, such as osmotic stress, hypoxia or serum starvation do not affect TRB3 expression. Thus, TRB3 may function as a nutrient sensor. Inhibition of TRB3 expression has no effect on growth of PC-3 cells under regular growth conditions. However, in the absence of glucose overexpression of TRB3 in PC-3 cells can interfere with apoptosis and restore growth on extracellular matrix. Taken together, our data point to an important role of TRB3 in sensing reduced nutrient supplies and in providing survival signals during these periods.
authors.affiliation: Atugen AG (SR Pharma plc subsidiary), Otto Warburg Haus (Nr. 80), Robert-Roessle-Strasse 10, 13125 Berlin, Germany. kaufmann@atugen.com
authors.forename: Rolf
authors.initials: R
authors.lastname: Schwarzer
authors.forename: Sybille
authors.initials: S
authors.lastname: Dames
authors.forename: Daniel
authors.initials: D
authors.lastname: Tondera
authors.forename: Anke
authors.initials: A
authors.lastname: Klippel
authors.forename: Joerg
authors.initials: J
authors.lastname: Kaufmann
mesh_terms: D000601:Amino Acids, Essential / Q000172:deficiency* / Q000494:pharmacology; D018797:Cell Cycle Proteins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000737:chemistry / Q000494:pharmacology; D005947:Glucose / Q000172:deficiency* / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D008297:Male; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism* / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000473:pathology; D017346:Protein Serine-Threonine Kinases / Q000187:drug effects / Q000235:genetics / Q000378:metabolism* / Q000037:antagonists & inhibitors; D012333:RNA, Messenger / Q000096:biosynthesis; D012097:Repressor Proteins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D015533:Transcriptional Activation
chemical_list: D000601:Amino Acids, Essential; D018797:Cell Cycle Proteins; D017077:Culture Media, Conditioned; D005947:Glucose; D019869:Phosphatidylinositol 3-Kinases; D017346:Protein Serine-Threonine Kinases; D012333:RNA, Messenger; D012097:Repressor Proteins; C474831:TRIB3 protein, human